Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HYMPAVZI S.C. INJECTION 150 MG PEN SPECIAL INVESTIGATION

NCT07161687 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT07161687
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07161687 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HYMPAVZI S.C. INJECTION 150 MG PEN SPECIAL INVESTIGATION
Lead sponsor
Pfizer
Phase
Observational
Overall status
Active, not recruiting
Start date
October 30, 2025
Completion date
April 11, 2030
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia a or b